AG

Ankush Garg

Active Director Designated Partner DIN 11083134
DIN 11083134 First appointment Apr 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Apr 2025
Shareholding value Locked Premium profile

About Ankush Garg

Ankush Garg has 1 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Rancin Pharmaceutical Llp. Engaged in General Business. Contributes to corporate operations.

DIN 11083134
Primary Designation Designated Partner
First Appointment 30 Apr 2025
Oldest Company Age 1 yrs

Current companies

Company Designation Appointment Founded Status
Designated Partner 30 Apr 2025 2025 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rancin Pharmaceutical Llp
Premium access

Shareholding and investment profile for Ankush Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankush Garg

Ankush Garg has 1 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Rancin Pharmaceutical Llp. Engaged in General Business. Contributes to corporate operations.

Ankush Garg is associated with 1 company as Designated Partner.

Ankush Garg has expertise in General Business.

Ankush Garg has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available